Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Lei Zhu
Affiliation
Emory University School of Medicine
ORCID
Career Start Year
2010
Papers
75
H Index
36
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36632237
Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy.
Int J Nanomedicine
2023
36115156
Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer.
Biomater Adv
2022
35396932
Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
2022
36256454
Inhibition of NADPH Oxidase-ROS Signal using Hyaluronic Acid Nanoparticles for Overcoming Radioresistance in Cancer Therapy.
ACS Nano
2022
34289988
Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib.
Cancer Res
2021
33905036
Rictor, an essential component of mTOR complex 2, undergoes caspase-mediated cleavage during apoptosis induced by multiple stimuli.
Apoptosis
2021
34298765
Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells.
Cancers (Basel)
2021
32272454
Construction and evaluation of hyaluronic acid-based copolymers as a targeted chemotherapy drug carrier for cancer therapy.
Nanotechnology
2020
32896851
The development of a Glypican-3-specific binding peptide using <i>in vivo</i> and <i>in vitro</i> two-step phage display screening for the PET imaging of hepatocellular carcinoma.
Biomater Sci
2020
30824801
Palladium based nanoparticles for the treatment of advanced melanoma.
Sci Rep
2019
31603456
Glypican-3 (GPC3) targeted Fe<sub>3</sub>O<sub>4</sub> core/Au shell nanocomplex for fluorescence/MRI/photoacoustic imaging-guided tumor photothermal therapy.
Biomater Sci
2019
31482934
Noninvasive monitoring of the development and treatment response of ischemic hindlimb by targeting matrix metalloproteinase-2 (MMP-2).
Biomater Sci
2019
30856555
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations.
Transl Oncol
2019
29107218
Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
Biomaterials
2018
29648446
Evans Blue Derivative-Functionalized Gold Nanorods for Photothermal Therapy-Enhanced Tumor Chemotherapy.
ACS Appl Mater Interfaces
2018
29086481
Theranostic Hyaluronic Acid-Iron Micellar Nanoparticles for Magnetic-Field-Enhanced inâ¿¿vivo Cancer Chemotherapy.
ChemMedChem
2018
27776285
Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy.
Biomaterials
2017
28277675
Correction to "Novel <sup>19</sup>F Activatable Probe for the Detection of Matrix Metalloprotease-2 Activity by MRI/MRS".
Mol Pharm
2017
29097925
Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug.
Contrast Media Mol Imaging
2017
29114172
Theranostic Probes for Cancer Imaging.
Contrast Media Mol Imaging
2017
28875691
Construction and Evaluation of a Targeted Hyaluronic Acid Nanoparticle/Photosensitizer Complex for Cancer Photodynamic Therapy.
ACS Appl Mater Interfaces
2017
27876448
Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Nanomedicine (Lond)
2017
27862961
Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.
Macromol Biosci
2017
27916607
Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.
Cancer Lett
2017
26691399
Hybrid graphene/Au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy.
Biomaterials
2016
26641886
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
Bioconjug Chem
2016
27392290
Functional long circulating single walled carbon nanotubes for fluorescent/photoacoustic imaging-guided enhanced phototherapy.
Biomaterials
2016
27121639
Monitoring of the tumor response to nano-graphene oxide-mediated photothermal/photodynamic therapy by diffusion-weighted and BOLD MRI.
Nanoscale
2016
26860184
Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy.
ACS Appl Mater Interfaces
2016
26877782
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.
Theranostics
2016
26850086
Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging.
Bioconjug Chem
2016
26845246
Diffusion-Weighted Magnetic Resonance Imaging for Therapy Response Monitoring and Early Treatment Prediction of Photothermal Therapy.
ACS Appl Mater Interfaces
2016
26234690
A novel single walled carbon nanotube (SWCNT) functionalization agent facilitating in vivo combined chemo/thermo therapy.
Nanoscale
2015
26388178
Activatable Ferritin Nanocomplex for Real-Time Monitoring of Caspase-3 Activation during Photodynamic Therapy.
ACS Appl Mater Interfaces
2015
26581247
Role of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe.
Sci Rep
2015
26681988
Noninvasive Dynamic Imaging of Tumor Early Response to Nanoparticle-mediated Photothermal Therapy.
Theranostics
2015
23982795
Comparison of three dimeric 18F-AlF-NOTA-RGD tracers.
Mol Imaging Biol
2014
25250628
99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
PLoS One
2014
25271556
Novel 19F activatable probe for the detection of matrix metalloprotease-2 activity by MRI/MRS.
Mol Pharm
2014
25402600
Activatable hyaluronic acid nanoparticle as a theranostic agent for optical/photoacoustic image-guided photothermal therapy.
ACS Nano
2014
24465271
Visualization of protease activity in vivo using an activatable photo-acoustic imaging probe based on CuS nanoparticles.
Theranostics
2014
24266806
Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity.
ACS Chem Biol
2014
22588595
Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI.
Mol Imaging Biol
2013
23884164
Gadolinium embedded iron oxide nanoclusters as T1-T2 dual-modal MRI-visible vectors for safe and efficient siRNA delivery.
Nanoscale
2013
23607644
Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs).
Mol Pharm
2013
23683064
Gold nanoparticle-based activatable probe for sensing ultralow levels of prostate-specific antigen.
ACS Nano
2013
23750453
Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.
Bioconjug Chem
2013
23770832
VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle.
Nanoscale
2013
23731122
Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots.
ACS Nano
2013
23471295
Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.
Theranostics
2013
1 - 50 of 75
Column Actions
Search
Recommended Authors
Gyoyeon Hwang
University of Notre Dame
Career Start Year
2015
Number of shared co-authors
0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year
2013
Number of shared co-authors
2
Yimei Lu
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Nan Jin
University of California San Francisco
Career Start Year
2011
Number of shared co-authors
0
Thinzar M Lwin
City of Hope National Medical Center
Career Start Year
2011
Number of shared co-authors
0
Ye Yuan
Southwest Hospital, Army Medical University
Career Start Year
2011
Number of shared co-authors
0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Jeroen A C M Goos
Karolinska Institutet
Career Start Year
2009
Number of shared co-authors
0
Nimit L Patel
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.
Career Start Year
2008
Number of shared co-authors
0
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
1
Ligong Lu
Guangdong General Hospital, Guangdong Academy of Medical Sciences
Career Start Year
2007
Number of shared co-authors
1
Hee Jin Cho
Touro College of Osteopathic Medicine
Career Start Year
2007
Number of shared co-authors
0
Xiao-Peng He
Ottawa Hospital Research Institute
Career Start Year
2006
Number of shared co-authors
0
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year
2005
Number of shared co-authors
0
Wouter H P Driessen
The University of Texas M.D. Anderson Cancer Center
Career Start Year
2004
Number of shared co-authors
0
Ludwig Dubois
Maastricht University
Career Start Year
2004
Number of shared co-authors
0
Na Zhang
Guizhou University of Traditional Chinese Medicine
Career Start Year
2004
Number of shared co-authors
0
Natasja G Lieuwes
Maastricht University
Career Start Year
2003
Number of shared co-authors
0
Nan Du
Institute for Solid State Physics, Friedrich Schiller University Jena
Career Start Year
2003
Number of shared co-authors
0
Trevor D McKee
University Health Network
Career Start Year
2001
Number of shared co-authors
0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year
1999
Number of shared co-authors
0
Nobuyuki Kosaka
University of Fukui.
Career Start Year
1997
Number of shared co-authors
0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
0
Mei He
Sichuan University
Career Start Year
1992
Number of shared co-authors
4
Hisataka Kobayashi
Center for Cancer Research
Career Start Year
1990
Number of shared co-authors
1
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year
1990
Number of shared co-authors
0
James P Basilion
Case Western Reserve University
Career Start Year
1985
Number of shared co-authors
0
Martin W Brechbiel
National Institutes of Health
Career Start Year
1985
Number of shared co-authors
1
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Career Start Year
1978
Number of shared co-authors
0
Peter S Conti
Keck School of Medicine of USC
Career Start Year
1971
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers
42
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers
33
Fan Zhang
The Second Hospital of Dalian Medical University
Co-authored papers
23
Ying Ma
National Institutes of Health
Co-authored papers
19
Seulki Lee
The Johns Hopkins University School of Medicine
Co-authored papers
17
Dale O Kiesewetter
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers
14
Lixin Lang
First Hospital of Shanxi Medical University, Shanxi Medical University
Co-authored papers
9
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Co-authored papers
8
Hak Soo Choi
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
4
Jinxia Guo
Co-authored papers
4
Henry S Eden
Co-authored papers
2
Ruth M O'Regan
Co-authored papers
1
Qingguo Xie
College of Life Science and Technology, Huazhong University of Science and Technology
Co-authored papers
1
Quanzheng Li
Massachusetts General Hospital
Co-authored papers
1
Orit Jacboson
Co-authored papers
1
James R Mansfield
Institute for Biodiagnostics, National Research Council Canada
Co-authored papers
1
Chenxi Wu
College of Clinical Medicine, Jining Medical University
Co-authored papers
1
Benjamin G Barwick
Emory University School of Medicine
Co-authored papers
1
1 - 18